Research Analysts’ Recent Ratings Updates for Cooper Companies (COO)

Several analysts have recently updated their ratings and price targets for Cooper Companies (NYSE: COO):

  • 3/9/2018 – Cooper Companies had its “outperform” rating reaffirmed by analysts at BMO Capital Markets. They now have a $280.00 price target on the stock, up previously from $277.00.
  • 3/9/2018 – Cooper Companies was given a new $265.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a “hold” rating on the stock.
  • 3/9/2018 – Cooper Companies had its “hold” rating reaffirmed by analysts at Stephens. They now have a $270.00 price target on the stock.
  • 3/9/2018 – Cooper Companies had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $285.00 price target on the stock.
  • 3/8/2018 – Cooper Companies was downgraded by analysts at TheStreet from a “b” rating to a “c” rating.
  • 2/9/2018 – Cooper Companies was downgraded by analysts at Cleveland Research from a “buy” rating to a “hold” rating.

Shares of Cooper Companies stock traded down $4.46 during midday trading on Monday, reaching $231.23. 250,242 shares of the company’s stock traded hands, compared to its average volume of 492,106. The company has a quick ratio of 1.61, a current ratio of 2.83 and a debt-to-equity ratio of 0.75. Cooper Companies Inc has a 1-year low of $194.01 and a 1-year high of $260.26. The company has a market cap of $11,553.85, a price-to-earnings ratio of 66.26, a PEG ratio of 1.85 and a beta of 0.61.

How to Become a New Pot Stock Millionaire

Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, March 8th. The medical device company reported $2.79 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.51 by $0.28. Cooper Companies had a net margin of 7.83% and a return on equity of 16.90%. The business had revenue of $590.00 million during the quarter, compared to analyst estimates of $583.07 million. During the same period in the prior year, the business earned $1.93 EPS. The company’s revenue for the quarter was up 18.2% on a year-over-year basis. research analysts expect that Cooper Companies Inc will post 11.83 EPS for the current year.

In related news, Director Allan E. Rubenstein sold 500 shares of the stock in a transaction dated Wednesday, December 27th. The shares were sold at an average price of $222.00, for a total value of $111,000.00. Following the completion of the transaction, the director now directly owns 6,590 shares in the company, valued at approximately $1,462,980. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Robert S. Weiss sold 36,769 shares of the stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $242.35, for a total transaction of $8,910,967.15. Following the completion of the transaction, the chief executive officer now owns 135,936 shares of the company’s stock, valued at $32,944,089.60. The disclosure for this sale can be found here. Insiders sold a total of 62,081 shares of company stock valued at $14,879,687 over the last 90 days. Company insiders own 1.60% of the company’s stock.

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Reviewing Government Properties Income Trust  and Innovative Industrial
Reviewing Government Properties Income Trust and Innovative Industrial
Sky Solar  & Its Rivals Head-To-Head Comparison
Sky Solar & Its Rivals Head-To-Head Comparison
Analyzing Calyxt  & The Competition
Analyzing Calyxt & The Competition
Michael Bruce Sells 4,444,444 Shares of Purplebricks Group PLC  Stock
Michael Bruce Sells 4,444,444 Shares of Purplebricks Group PLC Stock
Robert T. E. Ware Buys 25,000 Shares of Tarsus Group  Stock
Robert T. E. Ware Buys 25,000 Shares of Tarsus Group Stock
Insider Buying: ClearStar  Insider Acquires 33,660 Shares of Stock
Insider Buying: ClearStar Insider Acquires 33,660 Shares of Stock


© 2006-2018 Ticker Report. Google+.